A detailed history of Sierra Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sierra Capital LLC holds 247 shares of LLY stock, worth $184,758. This represents 0.03% of its overall portfolio holdings.

Number of Shares
247
Previous 247 -0.0%
Holding current value
$184,758
Previous $224,000 2.23%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $179,042 - $224,532
247 New
247 $224,000
Q3 2022

Nov 04, 2022

SELL
$296.48 - $337.87 $3,854 - $4,392
-13 Reduced 4.13%
302 $98,000
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $5,853 - $6,872
-21 Reduced 6.25%
315 $102,000
Q1 2022

May 03, 2022

BUY
$234.69 - $291.66 $2,112 - $2,624
9 Added 2.75%
336 $96,000
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $17,988 - $22,323
80 Added 32.39%
327 $90,000
Q1 2021

May 28, 2021

BUY
$164.32 - $212.72 $40,587 - $52,541
247 New
247 $46,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sierra Capital LLC Portfolio

Follow Sierra Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Capital LLC with notifications on news.